{
event: "article_read",
name: `Exercise and Diabetes, we've asked the experts for their opinion at ATTD 2023`,
author: ``,
tags: `Diabète | Diabète De Type 1`,
publication_date: ``,
interaction_type: "content"
}
Explorer
Explorer
Exercise and Diabetes, we've asked the experts for their opinion at ATTD 2023
View the full Webinar Recording
03-01 M2 Sanofi - webinar DEF 3
Watch the Highlight Video
Highlight video - Exercise webinar
Podcast with Dr. Dehout
FR Dr. Dehout Diabetes & Exercise
Podcast with Dr. Marlier
NL Dr. Marlier Diabetes & Exercise
Exercise and Diabetes, we've asked the experts for their opinion at ATTD 2023
Exercise and Diabetes
Podcast Highlights Webinar
Diabetes webinar VF
Articles liés
Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.1 The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.2 Assays for detecting autoimmune T1D have shown high sensitivity and specificity.3,4
Autoimmune Type 1 Diabetes
The Type 1 Diabetes (T1D) field is evolving.
Recognition of the presymptomatic stages in T1D is growing.1-4
The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2
